Exchange: NYSE·Updated 07:30 PM EST

About ANRO

About

Alto Neuroscience, Inc. is a clinical-stage biopharmaceutical company, which engages in the development of psychiatric drugs. Its pipeline is composed of five clinical-stage assets which initially target depressive disorder and schizophrenia population. The company was founded by Amit Etkin, Dan Segal, and Wei Wu on March 25, 2019 and is headquartered in Mountain View, CA.
Sector:
Health Technology
Industry:
Biotechnology
Employees:
68

Frequently Asked Questions

Advertisement|Remove ads.